Optimal Cerebral Perfusion Pressure Guided Therapy: Assessment of Target Effectiveness - II
- Sponsor
- Maastricht University Medical Center
- Study ID
- NCT07287358
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cerebral Perfusion Pressure
- Intracranial Pressure
- Severe Traumatic Brain Injury
- Traumatic Brain Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Optimal cerebral perfusion pressure — OTHERThe intervention group will receive CPPopt guided management with updated CPPopt targets every 4 hours. All other parameters will be handled according to Brain Trauma Foundation (BTF) guidelines.
Study Details
After severe traumatic brain injury, adequate blood flow to the brain is essential for recovery. This depends on arterial blood pressure, yet intensive care units apply fixed targets to all patients - treating every brain and patient the same. This study aims to change that. With new technology, 'optimal' blood pressure can be determined for each individual brain and treatment can be tailored accordingly. This personalized approach to neurocritical care has never been tested in a randomized controlled study before. If effective in showing reduced brain damage biomarkers, it will fundamentally transform brain injury treatment and dramatically improve recovery outcomes for patients worldwide.
Key Dates
- First listed
- Dec 17, 2025
- Start date
- May 1, 2026
- Status verified
- Dec 2025
- Primary completion
- May 1, 2028
- Completion
- May 15, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: CPPopt treatmentThe CPPopt treatment group will receive management according to the Brain Trauma Foundation (BTF) guidelines, except for the targeted cerebral perfusion pressure. Here, the calculated "optimal cerebral perfusion pressure (CPPopt)" will be targeted, with updated CPPopt targets every 4 hours.
- No Intervention: Control groupThe intervention group will receive standard brain trauma management according to the Brain Trauma Foundation (BTF) guidelines, including the standard cerebral perfusion pressure target of 60-70 mmHg.
Primary Outcome Measure
Cumulative concentration of blood biomarker Glial Fibrillary Acidic Protein (GFAP) during first 5 days of ICU admission [ Time Frame: The first 5 days of ICU admission ]
Central Contacts
- Marcel Aries, dr.0031-43-3876387
- Rik Hendrix, dr.0031-433874373
Related Studies
- Hyperbaric Oxygen Brain Injury Treatment TrialPHASE2 · Recruiting · Gaylan Rockswold · San Diego, California
- Mobile Health Self-Management and Support System for Chronic and Complex Health ConditionsRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- The National Center for Testing Treatments in Chronic Spinal Cord and Traumatic Brain InjuryEnrolling By Invitation · The University of Texas Health Science Center, Houston · Houston, Texas
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut